Skip to main content

Newsroom press releases

16/12/19 - 14:10

Diasorin receives FDA clearance for Simplexa VZV Swab Direct Molecular assay (571.47 KB)
Products Molecular

06/12/19 - 18:12

Press Release (262.61 KB)
Other

06/12/19 - 18:11

Press Release (262.7 KB)
Other

06/12/19 - 18:08

Communication on total amount of voting rights (281.87 KB)
Other

27/11/19 - 7:59

DIASORIN LAUNCHES THE LIAISON QUANTIFERON-TB GOLD PLUS ASSAY IN PARTNERSHIP WITH QIAGEN IN THE US MARKET (531.97 KB)
Products Immunodiagnostic

11/11/19 - 9:46

DIASORIN LAUNCHES PRIMER PAIR FOR CANDIDA AURIS IN THE US MARKET (159.93 KB)
Products Molecular

06/11/19 - 13:00

Record free cash flow generation along with growth in revenues and profitability for DiaSorin in the first 9 months of 2019 (621.09 KB)
Financial Data

30/10/19 - 9:55

DIASORIN LAUNCHES LIAISON® XL ZIKA CAPTURE IgM II TEST FOR THE DETECTION OF ZIKA VIRUS IN THE US MARKET (579.27 KB)
Products Immunodiagnostic

22/10/19 - 14:10

DIASORIN LAUNCHES LIAISON HCV TEST FOR HEPATITIS C DIAGNOSIS IN THE US MARKET (358.37 KB)
Products Immunodiagnostic

07/10/19 - 10:20

Communication on total amount of voting rights (282.21 KB)
Other

24/09/19 - 10:10

DiaSorin launches VZV Direct molecular test in Europe (369.67 KB)
Products Molecular

31/07/19 - 13:00

DiaSorin Board of Directors approves first half 2019 results. Growth in revenues and profitability. (687.57 KB)
Financial Data

10/06/19 - 18:23

DiaSorin presents its 2019-2022 Industrial Plan (548.2 KB)
Financial Data

05/06/19 - 7:38

DiaSorin and QIAGEN collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease (448.98 KB)
Acquisition / Partnership Immunodiagnostic

29/05/19 - 15:06

DiaSorin launches VZV DIRECT molecular test in the United States (360.87 KB)
Products Molecular

09/05/19 - 13:14

DiaSorin Group reports growth in profitability and strong free cash flow generation in the first quarter 2019 (728.82 KB)
Financial Data

06/05/19 - 15:19

DiaSorin launches ELASTASE-1 test for the diagnosis of chronic exocrine pancreatitis on LIAISON XL (416.77 KB)
Products Immunodiagnostic

30/04/19 - 12:28

Update Annual Calendar of Corporate Events 2019 (249.43 KB)
Other

24/04/19 - 17:24

DiaSorin: Shareholders' Meeting 2019 (449.66 KB)
Other

12/04/19 - 8:59

Communication on total amount of voting rights (320.44 KB)
Other

05/04/19 - 9:33

Communication on total amount of voting rights (342.47 KB)
Other

03/04/19 - 20:18

Lists publication (79.68 KB)
Other

03/04/19 - 10:32

DiaSorin launches the anaemia panel on Liaison XL in Europe (416.47 KB)
Products Immunodiagnostic

14/03/19 - 14:16

Growth in revenues, profitability and net profit in 2018 (1.03 MB)
Financial Data

07/03/19 - 11:45

Communication on total amount of voting rights (350.08 KB)
Other

06/03/19 - 8:45

A new Group website for DiaSorin: www.diasoringroup.com (154.5 KB)
Other

07/02/19 - 15:15

Communication on total amount of voting rights (February 7, 2019) (349.86 KB)
Other

31/01/19 - 22:30

DiaSorin launches FDA-cleared LIAISON Calprotectin test in the US market (528.02 KB)
Products Immunodiagnostic

03/01/19 - 13:30

DiaSorin launches Simplexa Bordetella Direct Molecular test in the United States (428.56 KB)
Products Molecular

21/12/18 - 11:30

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)
Products Molecular

04/12/18 - 8:00

DiaSorin's stocks listed in the FTSE MIB (464.63 KB)
Financial Data

19/11/18 - 15:00

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)
Products Molecular

07/11/18 - 13:00

DiaSorin Group reports growth in revenues and net profit in the first nine months of 2018 (961.72 KB)
Financial Data

17/10/18 - 11:51

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)
Products Molecular

12/10/18 - 11:47

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)
Products Molecular

09/10/18 - 11:35

DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom (471.21 KB)
Acquisition / Partnership

17/09/18 - 11:28

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)
Products Immunodiagnostic

07/08/18 - 8:45

Communication on total amount of voting rights (305.24 KB)
Financial Data

02/08/18 - 12:45

The Board of Directors approves the results for the first half of 2018 (883.1 KB)
Financial Data

27/07/18 - 12:00

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)
Products Immunodiagnostic

03/07/18 - 18:30

Conclusion treasury shares buy-back plan (397.33 KB)
Financial Data

03/07/18 - 18:30

Annex 3F (treasury shares buy back July 2018) (6.59 KB)
Financial Data

03/07/18 - 18:30

Report treasury shares buy-back (287.99 KB)
Financial Data

03/07/18 - 18:30

Annex 3F (treasury shares buy back June 2018) (8.69 KB)
Financial Data

29/06/18 - 18:15

Weekly report treasury shares buy-back (290.62 KB)
Financial Data

22/06/18 - 20:30

Weekly report treasury shares buy-back (290.6 KB)
Financial Data

15/06/18 - 21:00

Weekly report treasury shares buy-back (290.62 KB)
Financial Data

12/06/18 - 14:15

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)
Products Molecular

08/06/18 - 23:15

Weekly report treasury shares buy-back (290.24 KB)
Financial Data

04/06/18 - 13:15

Annex 3F (treasury shares buy back May 2018) (8.54 KB)
Financial Data

01/06/18 - 20:15

Weekly report treasury shares buy-back (290.38 KB)
Financial Data

25/05/18 - 22:30

Weekly report treasury shares buy-back (289.97 KB)
Financial Data

19/05/18 - 1:45

Weekly report treasury shares buy-back (289.76 KB)
Financial Data

11/05/18 - 20:15

Weekly report treasury shares buy-back (290.77 KB)
Financial Data

08/05/18 - 14:30

The DiaSorin Group reports growth in revenues and profitability in the first quarter 2018 (832.84 KB)
Financial Data

03/05/18 - 20:15

Start up treasury shares buy-back plan (354.27 KB)
Financial Data

24/04/18 - 14:00

Annex 3F (treasury shares buy back) (7.77 KB)
Financial Data

23/04/18 - 18:30

Annual General Meeting 2018 (589.65 KB)
Financial Data

19/04/18 - 21:15

Conclusion treasury shares buy-back plan (397.59 KB)
Financial Data

19/04/18 - 21:00

Weekly report treasury shares buy-back (289.29 KB)
Financial Data

13/04/18 - 20:30

Weekly report treasury shares buy-back (290.07 KB)
Financial Data

06/04/18 - 19:45

Weekly report treasury shares buy-back (288.33 KB)
Financial Data

05/04/18 - 12:00

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)
Products Immunodiagnostic

04/04/18 - 20:00

Start up treasury shares buy-back plan (346.04 KB)
Financial Data

28/03/18 - 18:45

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)
Products Molecular

07/03/18 - 15:30

DiaSorin: FY 2017 Results (1.14 MB)
Financial Data

30/01/18 - 11:45

DiaSorin signs an agreement with the Italian Tax Authority granting tax relief under the Italian Patent Box regime (574.68 KB)
Financial Data

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership